Financial Technology Industry News
- Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with KEYTRUDA® (pembrolizumab) Presented at AACR Annual Meeting and Published in the New England Journal of Medicine
- KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival and Overall Response Rate Compared to Ipilimumab an Anti-CTLA-4 Therapy...
- Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer
- Mechanics Bank Celebrates Financial Literacy Month
- Sallie Mae Bank to Securitize Private Education Loans; Prices Residual Interest in Asset-Backed Securitization Trust